发明名称 B7-H3 AS A BIOMARKER FOR DIAGNOSING THE PROGRESSION AND EARLY LYMPH NODE METASTASIS OF CANCER
摘要 B7H3 is a ligand member of the immunoregulatory family of proteins on immune cells. In one embodiment, a method for diagnosing the progression of cancer with a high propensity of primary tumor metastasis to the lymph node or distant site is provided. Such a method may comprise obtaining a cancer tissue sample from a cancer patient, determining an expression level of B7-H3 present in the tissue sample, and diagnosing the progression of the cancer having a high propensity of primary tumor metastasis to the lymph node or distant site based upon the expression level, wherein an increased expression level correlates with an increased probability of having regional lymph nodes or organ site that are positive for metastases.
申请公布号 US2015301059(A1) 申请公布日期 2015.10.22
申请号 US201414226728 申请日期 2014.03.26
申请人 JOHN WAYNE CANCER INSTITUTE 发明人 Hoon Dave S.B.
分类号 G01N33/574;A61K47/48;C12Q1/68 主分类号 G01N33/574
代理机构 代理人
主权项 1. A method for diagnosing the progression of cancer with a high propensity of primary tumor metastasis to the lymph node or distant site comprising: obtaining a cancer tissue sample from a cancer patient; and determining an expression level of B7-H3 present in the tissue sample; and diagnosing the progression of the cancer having a high propensity of primary tumor metastasis to the lymph node or distant site based upon the expression level, wherein an increased expression level correlates with an increased probability of having regional lymph nodes or organ site that are positive for metastases.
地址 Santa Monica CA US